Published in Blood Weekly, October 12th, 1998
Eveline P. Mauser-Bunschoten, University Hospital Utrecht, Netherlands, and colleagues studied the prevalence of HGV-RNA and HGV-E2 antibodies in a cohort of Dutch hemophilia patients in terms of clotting products used, patient age, and coinfection with hepatitis C ("Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History," Blood, September 15, 1998;92:2164-2168).
"HGV infection is frequently seen in patients with hemophilia. This might be a result of the past use of non-...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1998-10-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.